Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach

• Published in: Toxicology (Amsterdam) 2022-01, Vol.465, p.153060-153060, Article 153060
• Main Authors: Fragki, Styliani, Hoogenveen, Rudolf, van Oostrom, Conny, Schwillens, Paul, Piersma, Aldert H., Zeilmaker, Marco J.
• Format: Article
• Language: English
• Subjects: Animals; BeWo; Biological Transport; Biomarkers - blood; Caproates - toxicity; Cell Line; Developmental toxicity; Dose-Response Relationship, Drug; Female; Fetal Blood - metabolism; Generic PBK model; Gestational Age; Glycolates - toxicity; Humans; Maternal-Fetal Exchange; Miconazole - toxicity; Models, Biological; Permeability; Phthalic Acids - toxicity; Pregnancy; Proof of Concept Study; QIVIVE; Rats; Reproducibility of Results; Risk Assessment; Silanes - toxicity; Toxicity Tests; Toxicokinetics; Transplacental transport; Triazoles - toxicity; Trophoblasts - drug effects; Trophoblasts - metabolism; Trophoblasts - pathology; Valproic Acid - toxicity
• ISSN: 0300-483X; 1879-3185
• DOI: 10.1016/j.tox.2021.153060

[Display omitted] With the increasing application of cell culture models as primary tools for predicting chemical safety, the quantitative extrapolation of the effective dose from in vitro to in vivo (QIVIVE) is of increasing importance. For developmental toxicity this requires scaling the in vitro observed dose-response characteristics to in vivo fetal exposure, while integrating maternal in vivo kinetics during pregnancy, in particular transplacental transfer. Here the transfer of substances across the placental barrier, has been studied using the in vitro BeWo cell assay and six embryotoxic compounds of different kinetic complexity. The BeWo assay results were incorporated in an existing generic Physiologically Based Kinetic (PBK) model which for this purpose was extended with rat pregnancy. Finally, as a “proof of principle”, the BeWo PBK model was used to perform a QIVIVE based on developmental toxicity as observed in various different in vitro toxicity assays. The BeWo results illustrated different transport profiles of the chemicals across the BeWo monolayer, allocating the substances into two distinct groups: the ‘quickly-transported’ and the ‘slowly-transported’. BeWo PBK exposure simulations during gestation were compared to experimentally measured maternal blood and fetal concentrations and a reverse dosimetry approach was applied to translate in vitro observed embryotoxicity into equivalent in vivo dose-response curves. This approach allowed for a direct comparison of the in vitro dose-response characteristics as observed in the Whole Embryo Culture (WEC), and the Embryonic Stem Cell test (cardiac:ESTc and neural:ESTn) with in vivo rat developmental toxicity data. Overall, the in vitro to in vivo comparisons suggest a promising future for the application of such QIVIVE methodologies for screening and prioritization purposes of developmental toxicants. Nevertheless, the clear need for further improvements is acknowledged for a wider application of the approach in chemical safety assessment.